Speaker Profile
Biography
Ferhan Qureshi has over 20 years of experience at biotechnology companies in the San Francisco Bay Area including roles at Genentech, Aviir, Crescendo Bioscience, and now Octave Bioscience leading cross-functional teams involved in the research and development of analytical techniques to support therapeutic development, lab developed tests (LDTs) and in-vitro diagnostic applications. Ferhan has led several successful cutting-edge projects with a primary focus on multiplex immunoassay techniques deployed within regulated environments (GLP and CLIA) to support products in oncology, cardiovascular, autoimmune, and neurodegenerative diseases.
Clinical Dx Showcase:
Octave Bioscience
Octave has launched a Precision Care Solution to improve outcomes for patients with multiple sclerosis. The Precision Care Solution incorporates enhanced MRI reports, tools for advanced clinical insights, and multiplex blood-based biomarker tests powered by Olink’s PEA methodology for quantitative and objective disease assessments.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative